NEW YORK, NY / ACCESSWIRE / January 10, 2019 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://marketedgereport.com and get exclusive access to our numerous research reports and market updates.
The Market Edge Initiates Coverage on:
Fennec Pharmaceuticals Inc.
Covalon Technologies Ltd.
Hemostemix's stock had no change Wednesday, to close the day at $0.10. The stock recorded a trading volume of 61,899 shares, which was below its three months average volume of 145,720 shares. In the last year, Hemostemix's shares have traded in a range of 0.05 - 0.14. The share price has gained 100% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.10 is greater than its 200-day moving average of $0.09. Shares of Hemostemix have gained approximately 81.82 percent in the last year.
Access The Market Edge's Hemostemix Inc. Research Report:
On Wednesday, shares of Fennec Pharmaceuticals recorded a trading volume of 500 shares, which was below the three months average volume of 1,971 shares. The stock ended the day 3.21% lower at $9.34. The share price has fallen 50.48% from its 52
Access The Market Edge's Fennec Pharmaceuticals Inc. Research Report:
Sernova's stock moved 2.56% lower Wednesday, to close the day at $0.19. The stock recorded a trading volume of 190,500 shares, which was above its three months average volume of 150,284 shares. In the last year, Sernova's shares have traded in a range of 0.17 - 0.47. The share price has gained 11.76% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.20 is lower than its 200-day moving average of $0.21. Shares of Sernova have fallen approximately 56.82 percent in the last year.
Access The Market Edge's
On Wednesday, shares of Covalon Technologies recorded a trading volume of 24,240 shares, which was above the three months average volume of 15,419 shares. The stock ended the day 8.75% higher at $4.35. The share price has fallen 53.97% from its 52
Access The Market Edge's Covalon Technologies Ltd. Research Report:
Our Actionable Research on Hemostemix Inc. (TSXV
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered
For any questions, inquiries, or comments reach out to us directly at:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.